UPDATE 1-SEC charges former Puma Biotech employee with insider trading
September 29, 2016 at 17:41 PM EDT
WASHINGTON, Sept 29 (Reuters) - A former executive for biopharmaceutical company Puma Biotechnology Inc was charged on Thursday by the top U.S. securities regulator and prosecutors with trading on inside information ahead of a company announcement about its breast cancer drug.
